The INMA’s Actenzymes project is among the ten technology companies to be funded by the CSIC’s Impulsa-T programme
As part of the CSIC’s open innovation hub, Converge, launched by the Vice-Presidency for Innovation and Transfer at the beginning of last year, the Impulsa-T programme focuses on the promotion and development of business ideas originating at the CSIC. Its main objective is to foster the creation of Knowledge-Based Companies (KBCs) dedicated to the commercialisation of CSIC technologies and knowledge. The last decade has seen a doubling in the formation of these KBEs based on the institution’s research results. These companies not only represent outstanding ways of bringing scientific advances to the market, but also play an essential role in technological maturation and the generation of highly qualified employment.
The 10 projects selected in Impulsa-T to receive financial support of up to 50,000 euros cover a range of key activities, from market research and commercial feasibility studies to prototype development, fundraising and professional profiles necessary for the creation of the CBEs. This comprehensive approach and the financial and technical support over a 12-month period will allow the entrepreneurs to refine their concepts, address potential challenges and establish a solid foundation for the future success of their companies and a thorough understanding of the challenges and crucial stages of their business plan.
The following 10 projects were selected as winners and will receive funding for the development of their ideas:
- Actenzymes: Remote nanoactivation of enzymes for use in biotechnology. From the Institute of Nanoscience and Materials of Aragon (INMA), a joint institute of the CSIC and the University of Zaragoza.
- Akelite: Thermoplastic resin for the manufacture of reusable composite materials. From the Institute of Polymer Science and Technology (ICTP).
Green phenol: One-step phenol production. From the Institute of Materials Science of Barcelona (ICMAB). - Mat-oftal. Materials for ophthalmological treatments. From the Institute of Materials Science of Barcelona (ICMAB).
- Ifabcell: Intelligent thermosensitive platform for cell culture and therapy. From the Institute of Polymer Science and Technology (ICTP). Inflagraf biotech: Pharmaceutical therapy for liver diseases. From the Institute of Chemical Technology (ITQ).
- Bio-inspired membranes: Bio-inspired membranes for skin regeneration. From the Catalan Institute of Nanoscience and Nanotechnology (ICN2). – Pharmavolt: Production of extracellular vesicles for new therapeutic approaches. From the Institute of Micro and Nanotechnology (INM-CNM).
- Photocrete: Photonic concrete with diurnal radiative cooling capacity. From the Centre for the Physics of Materials (CFM).
- Sure vision: Optical device to evaluate the refractive error of the eye. Daza de Valdés Institute of Optics (IO).
Each of the 10 projects will receive financial and technical support over the next 12 months to mature their business idea and to be able to move forward with the creation of an EBC.
Photo of human cells on a blue background
15-02-2024
